CM
GMAB icon

Caption Management’s Genmab GMAB Stock Holding History

Caption Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-302,400
Closed -$5.92M – 1638
2025
Q1 		$5.92M Buy
+302,400
New +$6.34M 0.06% 336

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caption Management's GMAB Position: Q2 2026 in Review

Caption Management opened a new position in Genmab (GMAB) in Q2 2026: 199,774 shares worth $5.49M. The stake represents 0.03% of the portfolio and ranks #557 among its holdings. This is a return to the name: Caption Management previously reported a position in GMAB as recently as Q1 2025.

Caption Management first reported a position in GMAB in Q1 2025 and has held it in 2 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Caption Management held 199,774 shares of Genmab worth $5.49M as of Q2 2026.
  • Genmab was a new Caption Management position in Q2 2026.
  • Genmab made up 0.03% of Caption Management's portfolio in Q2 2026, its #557 holding.
  • Caption Management first reported a position in Genmab in Q1 2025 and has held it in 2 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.